Treatment

IDERDOMIDE 1mg clinical trials

1 indexed studies · 0 currently recruiting

AuthorisedTherapeutic exploratory (Phase II)
A multi-center open-label phase 2 study of Ixazomib, Iberdomide and dexamethasone in elderly patients with multiple myeloma at first relapse
This study looks at a new combination of medicines (Ixazomib, Iberdomide, and Dexamethasone) for older people with multiple myeloma that has come back. It aims to see how well these drugs work together to control the disease.
For: Multiple myeloma
France